贝宁PCV13从单剂瓶转多剂瓶的决策过程与规划后勤影响
贝宁将13价肺炎球菌结合疫苗(PCV13)从单剂瓶(SDV)转为多剂瓶(MDV),采用WHO引入后评估(PIE)方案评估决策过程及规划后勤影响。转换后PCV13覆盖率和脱漏率未检测到影响,但开放瓶管理存在风险实践,中央冷库疫苗占用体积减少47%,每名完全免疫儿童净储存体积从69.5降至41 m3,PCV13开放瓶损耗率从3%升至7%。结论提示需更好的准备和规划。
要点
- 转换后PCV13覆盖率和脱漏率未检测到影响。
- 63%受访卫生人员知晓并应用WHO多剂瓶政策(MDVP)。
- 83%访问的卫生机构冷藏柜中发现已开瓶疫苗,PCV13 MDV占37%。
核心结论
- 贝宁PCV13从单剂瓶转多剂瓶的经验表明需要更好的准备和规划。
研究设计与样本
- 采用WHO引入后评估(PIE)方案,比较转换前后相似6个月期间的PCV13覆盖率和脱漏率,并观察免疫接种场次中的多剂瓶管理实践。
- 从储存能力、废物管理和疫苗损耗分析后勤影响。
主要发现
- 转换后PCV13覆盖率和脱漏率未检测到影响。
- 63%受访卫生人员知晓并应用WHO多剂瓶政策(MDVP)。
- 83%访问的卫生机构中发现已开瓶疫苗,PCV13 MDV(37%)是卫生机构冰箱中三大主要开放瓶疫苗之一。
- 83%卫生机构在免疫接种场次中观察到危险接种实践,主要危险实践为未标明开瓶日期和时间(56%)。
- 中央冷库疫苗占用体积减少47%,每名完全免疫儿童(FIC)净储存体积从69.5降至41 m3。
关键数值与推荐
- 转换后PCV13覆盖率和脱漏率与同时期接种的对照疫苗相比未检测到影响。
- 63%受访卫生人员知晓并应用WHO多剂瓶政策(MDVP)。
- 83%卫生机构发现已开瓶疫苗,PCV13 MDV占37%。
- 83%卫生机构存在危险接种实践,56%为未标明开瓶日期和时间。
- 中央冷库疫苗占用体积减少47%,每名完全免疫儿童净储存体积从69.5降至41 m3;废物量减少40%;开放瓶损耗率从3%升至7%。
临床怎么用
- 转换多剂瓶疫苗需加强卫生人员对多剂瓶政策(MDVP)的培训与执行监督。
- 应规范开瓶后日期和时间标注,减少危险接种实践。
- 多剂瓶可降低储存体积和废物量,但需关注开放瓶损耗率上升。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Benin, a country eligible for Gavi support, changed the presentation of the 13-valent pneumococcal vaccine (PCV13) from the single-dose vial (SDV) to the multi-dose vial (MDV). The present work aims to evaluate the process of making this decision as well as programmatic and logistic impacts. METHODS: WHO protocol for post-introduction evaluation (PIE) was used. Programmatic impact was evaluated by comparing PCV13 coverage and dropout rates with a comparator vaccine administered simultaneously over similar 6-month periods prior to and after the transition. This impact was also appreciated from observation of multi-dose vial management practices during immunization sessions. Logistic impact was measured from the analysis of storage capacities, waste management and vaccine losses. RESULTS: Decision to move to PCV13 MDV was taken at EPI level. Activities planned to support this switch were partially implemented. Impact on vaccination coverage and PCV13 dropout rates in relation with the transition to PCV13 MDV was not detected. The study found that 63% of the health staff surveyed knew and applied WHO's multidose vial policy (MDVP). Vaccines opened vials were found in 83% of health facilities visited. PCV13 MDV (37%) was one of the 3 main vaccines found with open vials in health facility refrigerators. Vaccination risky practices were observed during immunization sessions in 83% of health facilities. The main risky practice was the lack of indication of the date and hour of opening vials (56%). There was a reduction of the volume occupied by vaccines at central store by 47%. Net storage volume per fully immunized child (FIC) decreased from 69.5 to 41 m3. PCV13 MDV allows for 40% reduction in the amount of waste produced by vaccination. PCV13 open vial loss rate has increased from 3 to 7%. CONCLUSION: Benin's experience in transition to an MDV presentation of PCV13 reveals the need for better preparation and planning.
引用
- Kaucley L, Essoh TA, Ilboudo GP, et al. Decision making process, programmatic and logistic impact of the transition from a single-dose vial to a multi-dose vial of the 13-valent pneumococcal vaccine in Benin. Vaccine. 2020. PMID: 32893037. doi:10.1016/j.vaccine.2020.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。